Novo Nordisk leading Danish contributor to US elections

The global pharmaceutical leader has contributed considerably to the American elections, but some warn of a tarnished image

Novo Nordisk, the world's leading maker of diabetes medicine, is the leading Danish contributor to the upcoming US elections, according to statistics accumulated by Politiken Research.

The Bagsværd-based drug maker has contributed around one million kroner to various politicians, many of whom oppose President Barack Obama’s healthcare reform.

The healthcare reform, which was passed in 2010, is set to go into full effect in 2014, is expected to catalyse a decrease in the price of medicine and is likely to reduce the annual turnover for Novo Nordisk.

The financial support from the pharmaceutical giant is given through a political action committee (PAC), which Novo Nordisk has established in the US. PACs are not allowed to receive money directly from foreign companies, but it’s legal as long as the funds come from Novo Nordisk employees who are American citizens or hold permanent residence in the US.

But by supporting opponents of the healthcare reform, some are accusing the Danish company seems of contradicting its own ethical standards, which indicate that the company is “firmly committed to improving access to health”.

Esben Pedersen, of the Copenhagen Business School's Center for CSR, which looks at the social responsibility of companies, believes that Novo Nordisk backing Republican politicians is inconsistent with its stated mantra.

“If there is a systematic discrepancy between what Novo Nordisk said they want to do and those candidates which they support, then it is a problem for them,” Pedersen told Politiken newspaper.

But Mike Rulis, Novo Nordisk’s head of communications in Denmark, contended that the company does not have an official opinion on the healthcare reform and thus sees no problem in backing politicians who oppose it.

“Do we agree with everything they stand for? No, we don’t. And that goes for the Democratic and Republican candidates we have backed. But they do some things that we can identify with and want to part of furthering,” Rulis told Politiken.

Novo Nordisk is the world's leading producer of diabetic medicine, garnering 26.5 billion kroner in the US alone in 2011.




  • Chinese wind turbine companies sign pact to end race-to-the-bottom price war

    Chinese wind turbine companies sign pact to end race-to-the-bottom price war

    China’s 12 leading wind turbine makers have signed a pact to end a domestic price war that has seen turbines sold at below cost price in a race to corner the market and which has compromised quality and earnings in the sector.

  • Watch Novo Nordisk’s billion-kroner musical TV ad for Wegovy

    Watch Novo Nordisk’s billion-kroner musical TV ad for Wegovy

    Novo Nordisk’s TV commercial for the slimming drug Wegovy has been shown roughly 32,000 times and reached 8.8 billion US viewers since June.

  • Retention is the new attraction

    Retention is the new attraction

    Many people every year choose to move to Denmark and Denmark in turn spends a lot of money to attract and retain this international talent. Are they staying though? If they leave, do they go home or elsewhere? Looking at raw figures, we can see that Denmark is gradually becoming more international but not everyone is staying. 

  • Defence Minister: Great international interest in Danish military technology

    Defence Minister: Great international interest in Danish military technology

    Denmark’s Defence Minister Troels Lund Poulsen attended the Association of the Unites States Army’s annual expo in Washington DC from 14 to 16 October, together with some 20 Danish leading defence companies, where he says Danish drone technology attracted significant attention.

  • Doctors request opioids in smaller packs as over-prescription wakes abuse concerns

    Doctors request opioids in smaller packs as over-prescription wakes abuse concerns

    Doctors, pharmacies and politicians have voiced concern that the pharmaceutical industry’s inability to supply opioid prescriptions in smaller packets, and the resulting over-prescription of addictive morphine pills, could spur levels of opioid abuse in Denmark.

  • Housing in Copenhagen – it runs in the family

    Housing in Copenhagen – it runs in the family

    Residents of cooperative housing associations in Copenhagen and in Frederiksberg distribute vacant housing to their own family members to a large extent. More than one in six residents have either parents, siblings, adult children or other close family living in the same cooperative housing association.


  • Come and join us at Citizens Days!

    Come and join us at Citizens Days!

    On Friday 27 and Saturday 28 of September, The Copenhagen Post will be at International Citizen Days in Øksnehallen on Vesterbro, Copenhagen. Admission is free and thousands of internationals are expected to attend

  • Diversifying the Nordics: How a Nigerian economist became a beacon for inclusivity in Scandinavia

    Diversifying the Nordics: How a Nigerian economist became a beacon for inclusivity in Scandinavia

    Chisom Udeze, the founder of Diversify – a global organization that works at the intersection of inclusion, democracy, freedom, climate sustainability, justice, and belonging – shares how struggling to find a community in Norway motivated her to build a Nordic-wide professional network. We also hear from Dr. Poornima Luthra, Associate Professor at CBS, about how to address bias in the workplace.

  • Lolland Municipality launches support package for accompanying spouses

    Lolland Municipality launches support package for accompanying spouses

    Lolland Municipality, home to Denmark’s largest infrastructure project – the Fehmarnbelt tunnel connection to Germany – has launched a new jobseeker support package for the accompanying partners of international employees in the area. The job-to-partner package offers free tailored sessions on finding a job and starting a personal business.